BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32796926)

  • 21. CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer.
    Kim J; Cho YJ; Ryu JY; Hwang I; Han HD; Ahn HJ; Kim WY; Cho H; Chung JY; Hewitt SM; Kim JH; Kim BG; Bae DS; Choi CH; Lee JW
    Gynecol Oncol; 2020 Jan; 156(1):211-221. PubMed ID: 31776040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of sphingosine kinase 2 down-regulates ERK/c-Myc pathway and reduces cell proliferation in human epithelial ovarian cancer.
    Dai L; Wang W; Liu Y; Song K; Di W
    Ann Transl Med; 2021 Apr; 9(8):645. PubMed ID: 33987343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.
    Haddadi N; Lin Y; Simpson AM; Nassif NT; McGowan EM
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
    Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
    J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
    Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
    Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
    Tanfin Z; Serrano-Sanchez M; Leiber D
    Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}.
    Mertens-Walker I; Bolitho C; Baxter RC; Marsh DJ
    Endocr Relat Cancer; 2010 Jun; 17(2):335-49. PubMed ID: 20215102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression.
    Yuza K; Nakajima M; Nagahashi M; Tsuchida J; Hirose Y; Miura K; Tajima Y; Abe M; Sakimura K; Takabe K; Wakai T
    J Surg Res; 2018 Dec; 232():186-194. PubMed ID: 30463717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.
    Li X; Zhang NX; Ye HY; Song PP; Chang W; Chen L; Wang Z; Zhang L; Wang NN
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
    Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
    Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
    Yao N; Sun JQ; Yu L; Ma L; Guo BQ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S; Ji X; Wang R; Miao Y
    Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.
    Serrano-Sanchez M; Tanfin Z; Leiber D
    Endocrinology; 2008 Sep; 149(9):4669-79. PubMed ID: 18723875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer.
    Redjimi N; Gaudin F; Touboul C; Emilie D; Pallardy M; Biola-Vidamment A; Fernandez H; Prévot S; Balabanian K; Machelon V
    Mol Cancer; 2009 Oct; 8():83. PubMed ID: 19814803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.
    Bandara G; Muñoz-Cano R; Tobío A; Yin Y; Komarow HD; Desai A; Metcalfe DD; Olivera A
    Front Immunol; 2018; 9():631. PubMed ID: 29643855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation.
    Yamanaka M; Shegogue D; Pei H; Bu S; Bielawska A; Bielawski J; Pettus B; Hannun YA; Obeid L; Trojanowska M
    J Biol Chem; 2004 Dec; 279(52):53994-4001. PubMed ID: 15485866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.